Weight Loss Injections from a Doctor: How the Decision Actually Works

Both Mounjaro and Wegovy are licensed in the UK for weight management in adults — but only following a clinical assessment by a prescriber who reviews your full health picture, not just your BMI.
Treatment typically starts at the lowest dose and is titrated gradually by the prescriber; the starting dose is chosen to let your body adjust, not for immediate weight effect.
Common side effects are gastrointestinal (nausea, loose stools, indigestion and reduced appetite are the most frequently reported) and tend to ease after the first few weeks at a new dose.
You can verify any online pharmacy dispensing these medicines on the GPhC register before handing over a prescription or payment.

If you're looking into weight loss injections from a doctor, the short answer is this: in the UK, Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medicines, which means a qualified prescriber must assess your suitability before treatment can begin. No pharmacy, GP surgery or online clinic can dispense them without that clinical step. What varies between routes is how that assessment happens, how quickly, and what support sits around it. This page helps you understand the decision in front of you, so you can make it clearly.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The factors that shape which route is right for you — and what a good assessment looks like

What your doctor is actually weighing up

When a prescriber reviews a request for weight loss injections, they are not simply checking a BMI box. They are building a picture: your weight history, any conditions that raise your cardiovascular or metabolic risk, the medicines you already take, and contraindications that would rule certain treatments out. A history of pancreatitis, for instance, requires careful consideration before starting a GLP-1 medicine, and women using oral contraceptives starting tirzepatide are advised to add a non-oral method for the first four weeks and after each dose increase, because absorption of the pill may be reduced.

This is why a thorough consultation matters far more than a quick eligibility quiz. The NHS patient information for tirzepatide sets out a clear list of conditions and medicines your prescriber needs to know about. A good assessment surfaces all of them. It is also why the physical step of ID and live weight verification exists: a prescriber cannot responsibly set a starting dose without confidence in your baseline measurements.

The licensed thresholds are a starting point, not the whole story. Both Mounjaro and Wegovy are licensed for adults with a BMI of 30 or above, or 27 and above if at least one weight-related condition is present, such as high blood pressure, obstructive sleep apnoea or raised cholesterol. Lower BMI thresholds may apply for some ethnic backgrounds under UK clinical guidance. But meeting the number is not the same as being clinically suitable; the prescriber's job is to assess both.

NHS route versus private route: what each involves

The NHS route to weight loss injections exists, but it is carefully rationed. NICE recommended tirzepatide in December 2024 for NHS use, and the rollout is phased: from June 2025, access began for patients with a BMI of 40 or above alongside four or more specific weight-related conditions. A second cohort opened in June 2026, and further phases are expected through 2027. If you are wondering whether getting a weight loss injection from your GP is a realistic option right now, the answer depends largely on which phase of the rollout applies to your circumstances. Wegovy is available through specialist weight management services under a separate NICE recommendation, but waiting lists are long in most areas.

For people who do not meet NHS criteria yet, or who do not want to wait, a regulated private route is the legal alternative. This does not mean cutting corners on clinical rigour, it means the same prescription requirement is met through a GPhC-registered pharmacy and a qualified independent prescriber, without a referral or a waiting list. If the cost of private treatment is something you're weighing up, this page on why weight loss injections cost what they do explains the supply and regulatory factors that drive pricing across all providers.

What neither route allows is obtaining these medicines without a valid prescription from a registered prescriber. Sellers offering them on social media or through discount codes, with no clinical assessment involved, are operating outside the law, and the MHRA has seized millions of counterfeit doses over the past two years, some containing substances that caused serious harm. The MHRA's Yellow Card scheme is the right place to report any suspect seller.

What a responsible private assessment should include

Not all private services approach clinical review the same way. When you're deciding where to go, the process matters as much as the price. A responsible service will require a detailed health questionnaire, verify your identity and your current weight (live, not self-reported), check your GP record or notify your GP in line with GPhC guidance, and have a named prescriber (a real clinician, not an automated system) read your answers and make a decision the same day.

At nume, every consultation is personally reviewed by a GPhC-registered independent prescriber. If you order before noon on a weekday, treatment that has been clinically approved is dispatched the same day and arrives the next working day by tracked DPD delivery, plain packaging, no branding on the outside. That 12pm cut-off is a practical detail worth knowing if you're planning around work or the school run.

Transfer patients (people moving from another provider) are asked for evidence of their current dose and recent treatment history before a prescriber reviews an increase. That policy exists to protect you, not to add friction. Our clinical team takes the same approach to every case: the starting point is your safety, not your urgency.

Practical things to think through before your consultation

A few questions are worth having answers to before you speak to a prescriber. Do you have any history of pancreatitis, gallbladder problems or medullary thyroid carcinoma? Are you pregnant, breastfeeding or planning to conceive in the near future? These are not reasons to be embarrassed; they are the exact information a prescriber needs, and being upfront makes the assessment faster and safer. Weight loss injections are not recommended during pregnancy or while breastfeeding, and the licence does not extend to under-18s.

It is also worth being realistic about what to expect. In the SURMOUNT-1 trial, adults taking tirzepatide at the highest dose lost around 20–21% of body weight on average over 72 weeks, alongside diet and activity changes. Those are clinical trial figures, achieved with consistent use, lifestyle support and regular prescriber oversight, not a guaranteed personal outcome. The medicine works best as part of a structured approach, which is why ongoing clinical review after starting treatment is not an optional extra.

A common question at this stage is whether you can get weight loss injections from your doctor rather than going through a private pharmacy, and the honest answer is that it depends on your BMI, your weight-related conditions, and where you are in the country. Many people also ask more specifically whether they personally can get weight loss injections from their doctor, which comes down to the individual clinical criteria and local NHS availability in your area. For a broader look at the available treatment options, our overview of licensed weight loss injections in the UK covers how the two main medicines compare, and if you want to understand more about how doctor-prescribed weight loss injections work across both NHS and private settings, that page walks through the key differences. When you're ready to take the clinical assessment step, starting a free consultation with our prescribers is the practical next move.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions